SAIL Biomedicines CEO Guillaume Pfefer joins the Flagship Studio to share updates on SAIL’s platform and pipeline progress, and how the company is harnessing AI for the integrative design of RNA medicines. More from Flagship @ JPM2025 here.
Related Companies
- Sail Biomedicines Founded: 2017 / 2023
